跳到内容

肿瘤科

贫血的管理

红细胞生成刺激剂

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. （打开新窗口）

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

来源‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

检索‎: PubMed 29471514

DOI码‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 （打开新窗口）

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. （打开新窗口）

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.

来源‎: Acta Haematol 2007;117(3):162-7.

检索‎: PubMed 17148935

DOI码‎: 10.1159/000097464

https://www.ncbi.nlm.nih.gov/pubmed/17148935 （打开新窗口）

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. （打开新窗口）

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

来源‎: Am J Hematol 2013;88(12):990-6.

检索‎: PubMed 23873823

DOI码‎: 10.1002/ajh.23552

https://www.ncbi.nlm.nih.gov/pubmed/23873823 （打开新窗口）

Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. （打开新窗口）

Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Würschmidt F, Petry KU, Kimmig R, Elling D, Thomssen C, von Minckwitz G, Möbus V, Hinke A, Kümmel S, Budach V, Lichtenegger W, Schmid P.

来源‎: J Clin Oncol 2011;29(28):3791-7.

检索‎: PubMed 21860000

DOI码‎: 10.1200/JCO.2010.30.4899

https://www.ncbi.nlm.nih.gov/pubmed/21860000 （打开新窗口）

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. （打开新窗口）

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

来源‎: Cancer 2012;118(3):848-55.

检索‎: PubMed 21751205

DOI码‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 （打开新窗口）

Management of anemia in cancer patients. （打开新窗口）

Calabrich A, Katz A.

来源‎: Future Oncol 2011;7(4):507-17.

检索‎: PubMed 21463140

DOI码‎: 10.2217/fon.11.24

https://www.ncbi.nlm.nih.gov/pubmed/21463140 （打开新窗口）

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. （打开新窗口）

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

来源‎: BJU Int 2011;108(10):1582-7.

检索‎: PubMed 21443653

DOI码‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 （打开新窗口）

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. （打开新窗口）

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

来源‎: J Clin Oncol 2010;28(13):2239-45.

检索‎: PubMed 20368566

DOI码‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 （打开新窗口）

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation. （打开新窗口）

Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

来源‎: Br J Cancer 2011;105(9):1267-72.

检索‎: PubMed 21959870

DOI码‎: 10.1038/bjc.2011.395

https://www.ncbi.nlm.nih.gov/pubmed/21959870 （打开新窗口）

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome. （打开新窗口）

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

来源‎: J Intern Med 2017;281(3):284-99.

检索‎: PubMed 27926979

DOI码‎: 10.1111/joim.12579

https://www.ncbi.nlm.nih.gov/pubmed/27926979 （打开新窗口）

How I treat cancer-associated anemia. （打开新窗口）

Gilreath JA, Rodgers GM

来源‎: Blood 2020;136(7):801-13.

检索‎: PubMed 32556170

DOI码‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 （打开新窗口）

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. （打开新窗口）

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

来源‎: Eur J Haematol. 2023 110(4):354-61.

检索‎: PubMed 36480004

DOI码‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ （打开新窗口）

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes. （打开新窗口）

Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K.

来源‎: Int J Hematol 2015;102(4):401-12.

检索‎: PubMed 26323997

DOI码‎: 10.1007/s12185-015-1862-5

https://www.ncbi.nlm.nih.gov/pubmed/26323997 （打开新窗口）

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. （打开新窗口）

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

来源‎: Cancer 2013;119(1):107-14.

检索‎: PubMed 22744794

DOI码‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 （打开新窗口）

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. （打开新窗口）

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A, Thomssen C, Kurbacher C, Kuhn W, Nitz U, Runnebaum IB, Hinke A, Kreienberg R, Untch M; on behalf of the AGO Breast Study Group.

来源‎: J Natl Cancer Inst 2013;105(14):1018-26.

检索‎: PubMed 23860204

DOI码‎: 10.1093/jnci/djt145

https://www.ncbi.nlm.nih.gov/pubmed/23860204 （打开新窗口）

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. （打开新窗口）

Ohashi Y, Uemura Y, Fujisaka Y, Sugiyama T, Ohmatsu H, Katsumata N, Okamoto R, Saijo N, Hotta T.

来源‎: Cancer Sci 2013;104(4):481-5.

检索‎: PubMed 23331490

DOI码‎: 10.1111/cas.12105

https://www.ncbi.nlm.nih.gov/pubmed/23331490 （打开新窗口）

Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review. （打开新窗口）

Park S, Greenberg P, Yucel A, Farmer C, O'Neill F, De Oliveira Brandao C, Fenaux P

来源‎: Br J Haematol 2019;184(2):134-60.

检索‎: PubMed 30549002

DOI码‎: 10.1111/bjh.15707

https://www.ncbi.nlm.nih.gov/pubmed/30549002 （打开新窗口）

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. （打开新窗口）

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

来源‎: Support Care Cancer 2012;20(1):159-65.

检索‎: PubMed 21359879

DOI码‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 （打开新窗口）

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. （打开新窗口）

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

来源‎: Leuk Lymphoma. 2019;60(9):2324-7.

检索‎: PubMed 30773115

DOI码‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 （打开新窗口）

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. （打开新窗口）

Pronzato P, Cortesi E, van der Rijt CC, Bols A, Moreno-Nogueira JA, de Oliveira CF, Barrett-Lee P, Ostler PJ, Rosso R; for the EPO-INT-47 Study Group.

来源‎: Oncologist 2010;15(9):935-43.

检索‎: PubMed 20798194

DOI码‎: 10.1634/theoncologist.2009-0279

https://www.ncbi.nlm.nih.gov/pubmed/20798194 （打开新窗口）

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. （打开新窗口）

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

来源‎: Lung Cancer 2012;76(3):478-85.

检索‎: PubMed 22277104

DOI码‎: 10.1016/j.lungcan.2011.12.015

https://www.ncbi.nlm.nih.gov/pubmed/22277104 （打开新窗口）

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia. （打开新窗口）

Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G.

来源‎: Eur J Haematol 2016;97(1):33-8.

检索‎: PubMed 26341961

DOI码‎: 10.1111/ejh.12679

https://www.ncbi.nlm.nih.gov/pubmed/26341961 （打开新窗口）

静脉注射铁剂

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. （打开新窗口）

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

来源‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

检索‎: PubMed 29471514

DOI码‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 （打开新窗口）

Intravenous iron in oncology. （打开新窗口）

Auerbach M, Ballard H.

来源‎: J Natl Compr Canc Netw 2008;6(6):585-92.

检索‎: PubMed 18597712

https://www.ncbi.nlm.nih.gov/pubmed/18597712 （打开新窗口）

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. （打开新窗口）

Calleja JL, Delgado S, Del Val A, Hervás A, Larraona JL, Terán Á, Cucala M, Mearin F; Colon Cancer Study Group.

来源‎: Int J Colorectal Dis 2016;31(3):543-51.

检索‎: PubMed 26694926

DOI码‎: 10.1007/s00384-015-2461-x

https://www.ncbi.nlm.nih.gov/pubmed/26694926 （打开新窗口）

How I treat cancer-associated anemia. （打开新窗口）

Gilreath JA, Rodgers GM

来源‎: Blood 2020;136(7):801-13.

检索‎: PubMed 32556170

DOI码‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 （打开新窗口）

Total dose iron dextran infusion in cancer patients: is it SaFe2+? （打开新窗口）

Gilreath JA, Stenehjem DD, Rodgers GM.

来源‎: J Natl Compr Canc Netw 2012;10(5):669-76.

检索‎: PubMed 22570295

https://www.ncbi.nlm.nih.gov/pubmed/22570295 （打开新窗口）

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. （打开新窗口）

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

来源‎: Eur J Haematol. 2023 110(4):354-61.

检索‎: PubMed 36480004

DOI码‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ （打开新窗口）

Intravenous iron therapy to treat anemia in oncology: a mapping review of randomized controlled trials. （打开新窗口）

Lim J, Auerbach M, MacLean B, Al-Sharea A, Richards T

来源‎: Curr Oncol. 2023 24;30(9):7836-51.

检索‎: PubMed 37754484

DOI码‎: 10.3390/curroncol30090569

https://pubmed.ncbi.nlm.nih.gov/37754484/ （打开新窗口）

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. （打开新窗口）

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

来源‎: Cochrane Database Syst Rev 2016;(2):CD009624.

检索‎: PubMed 26845108

DOI码‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 （打开新窗口）

Perioperative anemia management in colorectal cancer patients: a pragmatic approach. （打开新窗口）

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M.

来源‎: World J Gastroenterol 2014;20(8):1972-85.

检索‎: PubMed 24587673

DOI码‎: 10.3748/wjg.v20.i8.1972

https://www.ncbi.nlm.nih.gov/pubmed/24587673 （打开新窗口）

Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries. （打开新窗口）

Parikh PM, Aggarwal S, Biswas G, Gulia S, Agarwala V, Basade M, Mohapatra PN, Vamshi KM, Warrier A, Prasad K, Roy P, Chandrakant MV, Malhotra H, Hingmire S, Paul D, Maniar V, Gupta A, Panda SS, Samar A, Rohatgi N, Dattatreya S, Krishnamurthy M, Thirumalairaj R

来源‎: South Asian J Cancer. 2023 15;12(2):93-9.

检索‎: PubMed 37969669

DOI码‎: 10.1055/s-0043-1771445

https://pubmed.ncbi.nlm.nih.gov/37969669/ （打开新窗口）

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. （打开新窗口）

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

来源‎: J Clin Oncol 2008;26(10):1619-25.

检索‎: PubMed 18375891

DOI码‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 （打开新窗口）

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. （打开新窗口）

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

来源‎: J Cancer Res Clin Oncol 2012;138(2):179-87.

检索‎: PubMed 21972052

DOI码‎: 10.1007/s00432-011-1072-3

https://www.ncbi.nlm.nih.gov/pubmed/21972052 （打开新窗口）

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. （打开新窗口）

Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.

来源‎: Ann Oncol 2013;24(2):475-82.

检索‎: PubMed 23071262

DOI码‎: 10.1093/annonc/mds338

https://www.ncbi.nlm.nih.gov/pubmed/23071262 （打开新窗口）

肿瘤科
贫血的管理
中文简体（广东话）
贫血的管理
https://assetsnffrgf-a.akamaihd.net/assets/ct/5a91b826b0/images/syn_placeholder_sqr.png

联络本地医院联络委员会代表

为治疗耶和华见证人的临床医疗人员提供的全球24小时免费服务。

联络

医疗资讯汇总

內容包括:处理出血和贫血的无输血医疗临床策略，耶和华见证人在医疗事务方面的宗教和伦理立场，耶和华见证人通过全球医院联络委员会系统为医学界提供的服务。

查看下载

影片

治疗耶和华见证人的临床医疗人员可选择的治疗方法，以及需要考虑的医学和伦理因素。

观看影片